Resisted Exercise and Kinesiology-Taping in Managing Knee Osteoarthritis

NCT07062822 | Not Yet Recruiting DMC

• 1 other identifier: Rec-01014 Jeyad Khan
• Study Type: interventional
• Target: 40
• Locations: 0 countries
• Sites: N/A

Brief Summary

The study aims the Role of Resisted Exercise and Kinesiology Taping in Managing Knee Osteoarthritis in Overweight and Obese Individuals.

Conditions

Knee Osteoarthritis

Keywords

knee osteoarthritis

Outcome Measures

Primary Outcomes (1)

• Visual Analogue Scale (VAS)

  A 10 cm horizontal line with "No Pain" (0) on the left and "Worst Pain" (10) on the right.

  3 weeks

Study Arms (2)

Group A

EXPERIMENTAL

Resisted exercises

Other: Resisted exercise

Group B

PLACEBO COMPARATOR

kinesio-tapping

Other: kinesiology tapping

Interventions

Resisted exercise OTHER

Patients in this group will be applied Kinesio taping 3 times per week over the study period of 6 weeks. Before the kinesio taping, the skin surface will be clean. Patients will positioned lying on their side, hip extended, and knee joint at 60° of flexion. The knee will be tape with an I-shaped kinesio tape starting at the origin of the rectus femoris, and a Y-shaped kinesio tape proximal to the superior patellar border. The taping will be no tension at its base, whereas the portion between the anchor and the superior patella will be stretched ≈40%.

Group A

kinesiology tapping OTHER

kinesiology tapping

Group B

Eligibility Criteria

• Age: 45 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Participants must have a clinical diagnosis of knee osteoarthritis, confirmed by imaging (e.g., X-ray, MRI) or a physician's diagnosis based on clinical evaluation. This ensures that participants actually have the condition being studied.
• Pain Level: Moderate pain (e.g., 3-6 on the Visual Analog Scale or VAS): Participants should experience moderate pain levels during activities of daily living (ADLs), such as walking, climbing stairs, or squatting. This level of pain should be sufficient to demonstrate the potential effects of the interventions (resisted exercise and kinesiotaping).
• Impairments related to knee pain, such as difficulty walking, bending, or climbing stairs
• Stable Medical Condition: Participants should have stable health with no significant comorbidities (e.g., uncontrolled cardiovascular diseases, severe arthritis in other joints, or neurological disorders)

You may not qualify if:

• Severe Knee Deformities or Structural Damage: Individuals with severe joint deformities or advanced OA (e.g., bone-on-bone contact as observed on radiographs) may be excluded, as they may not respond to conservative interventions like resisted exercise or kinesiotaping
• Recent Knee Surgery: Exclude participants who have undergone knee surgery (e.g., total knee replacement, arthroscopy) within the past 6-12 months, as recovery from surgery may confound the results of the study.
• Other Inflammatory Joint Disorders: Participants with other inflammatory joint diseases (e.g., rheumatoid arthritis, gout, or psoriatic arthritis) should be excluded to ensure that the results are specifically related to knee OA, not other conditions that affect the joints.

Sponsors & Collaborators

• Riphah International University: lead

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Study Officials

• Ataur Rahman, MS-PT (CPPT)

  Riphah International University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ataur Rahman, MS-PT

CONTACT

03038371112; ataur.rahman@riphah.edu.pk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 3, 2025
• First Posted: July 14, 2025
• Study Start: July 17, 2025
• Primary Completion: May 13, 2026
• Study Completion: May 13, 2026
• Last Updated: July 14, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share